Amgen

3 Drugmakers That Probably Have Lower Tax Rates Than You Do
Motley Fool
Sun, 11/13/16 - 11:57 am
taxes
Amgen
Gilead Sciences
Eli Lilly
FDA OKs Expanded Use of Amgen's Enbrel
Investopedia
Thu, 11/10/16 - 10:18 am
FDA
Amgen
Enbrel
pediatrics
psoriasis
Amgen Is a Total Battleground
TheStreet.com
Wed, 11/9/16 - 09:44 am
Amgen
earnings
Amid pricing scrutiny, Amgen CEO predicts more value-based contracts
BioPharma Dive
Tue, 11/1/16 - 09:52 am
Amgen
drug pricing
Pharma CEOs
Robert Bradway
Biogen’s Tecfidera, Amgen’s Enbrel tell a tale of pricing power and weakness
Fierce Pharma
Mon, 10/31/16 - 09:40 am
Biogen
Tecfidera
Amgen
Enbrel
drug pricing
Amgen Is Melting Down
Seeking Alpha
Mon, 10/31/16 - 09:06 am
Amgen
Amgen 3Q Net, Revenue Top Street Estimates
Investopedia
Fri, 10/28/16 - 05:46 pm
Amgen
earnings
Amgen Cut Expenses, Make Q3 Gains (AMGN)
Investopedia
Fri, 10/28/16 - 10:09 am
Amgen
earnings
These pricey cholesterol drugs aren’t selling. And that has the biotech industry sweating
Stat
Fri, 10/28/16 - 10:07 am
PCSK9 inhibitors
Amgen
Regeneron
Sanofi
Repatha
Praluent
statins
Could Pfizer's at-risk Inflectra launch set a biosimilars precedent for Amgen, Novartis?
Fierce Pharma
Mon, 10/24/16 - 09:50 am
Pfizer
drug launches
biosimilars
Inflectra
Amgen
Novartis
AbbVie Is Under Duress With Fierce Competition
Seeking Alpha
Thu, 10/20/16 - 09:20 am
AbbVie
Humira
biosimilars
Amgen
Baxalta
Shire
Biotech's Drop May Be From Fear of a Democratic Win
Investopedia
Fri, 10/14/16 - 11:30 am
biotech
Amgen
Illumina
biotech stocks
2016 Presidential election
AstraZeneca snaps up Amgen site in Colorado
BioPharma Dive
Thu, 10/13/16 - 03:30 pm
AstraZeneca
Amgen
Colorado
drug manufacturing
Amgen inks latest high price-tag research collaboration
BioPharma Dive
Tue, 10/4/16 - 10:14 pm
Amgen
R&D
Nuevolution
oncology
Neuroscience
AstraZeneca hands off another Amgen-partnered drug in a $1.5B deal with an acquisitive Allergan
Endpoints
Mon, 10/3/16 - 10:09 am
AstraZeneca
Amgen
Allergan
MEDI2070
ulcerative colitis
Crohn's Disease
Big Pharma vs Big Pharma in court battles over biosimilar drugs
Yahoo/Reuters
Mon, 10/3/16 - 09:58 am
Big Pharma
patents
biosimilars
Novartis
Amgen
Biogen
Sanofi
Merck
Eli Lilly
Pfizer
JNJ
Amgen’s Backup Plan for Kyprolis (AMGN)
Investopedia
Sun, 10/2/16 - 10:22 am
Amgen
Kyprolis
Multiple Myeloma
Amgen Maintains Migraine Drug Lead (AMGN)
Investopedia
Fri, 09/30/16 - 10:05 am
Amgen
migraines
erenumab
Novartis, Amgen rack up their first PhIII success in a crowded CGRP migraine drug field
Endpoints
Thu, 09/29/16 - 08:23 am
Novartis
Amgen
CGRP blockers
migraines
erenumab
Amgen and Arrowhead to develop gene-therapies for heart disease
Yahoo/Reuters
Thu, 09/29/16 - 08:18 am
Amgen
Arrowhead
R&D
gene therapy
heart disease

Pages